IAT-S2

N/A

Report date: 2025/12/31 13:23:33

Base Information

Drug NameIAT-S2
Drug Alias NameIAT-S2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of Actiontumor microenvironment regulator
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterAct Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInterAct Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A